ClinicalTrials.Veeva

Menu

Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans

N

Nanchang University

Status and phase

Completed
Early Phase 1

Conditions

Diabetes
NAFLD (Nonalcoholic Fatty Liver Disease)
Obesity

Treatments

Dietary Supplement: Raspberry ketone

Study type

Interventional

Funder types

Other

Identifiers

NCT06681597
I-MRER [2023] No. 68

Details and patient eligibility

About

To investigate the molecular mechanism of raspberry ketone on regulating obesity, the investigators studied the effect of raspberry ketone intake on FGF21 in plasma.

The age of the volunteers were 18-60 years old, both male and female, without diabetes, hypertension and other diseases.

After ingestion of raspberry ketone (500mg), 2ml of blood was collected at 0 hours, 3 hours and 6 hours , and the FGF21 content in plasma was measured using a commercial reagent kit.

In addition, the investigators also studied the effect of raspberry ketone intake on energy metabolism 0 hours, 0.5 hours, 3 hours and 6 hours after consuming raspberry ketone (500mg).

Enrollment

60 patients

Sex

All

Ages

20 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

No drugs were taken before the human study

Exclusion criteria

Patients with hypertension

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Human administrated with raspberry ketone
Experimental group
Treatment:
Dietary Supplement: Raspberry ketone
Human administrated with placebo
Experimental group
Treatment:
Dietary Supplement: Raspberry ketone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems